| pubmed-article:3260986 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0033147 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0013030 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0000097 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0035331 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0205373 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C1550605 | lld:lifeskim |
| pubmed-article:3260986 | lifeskim:mentions | umls-concept:C0456205 | lld:lifeskim |
| pubmed-article:3260986 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:3260986 | pubmed:dateCreated | 1988-8-31 | lld:pubmed |
| pubmed-article:3260986 | pubmed:abstractText | Following MPTP administration, 4 Cynomolgus monkeys developed a parkinsonian syndrome, accompanied by specific changes of both pattern visual evoked potential and electroretinogram. Retinal dopamine and dihydroxyphenylacetic acid contents were measured in the 4 MPTP-treated monkeys and in 3 normal monkeys. Dopamine and dihydroxyphenylacetic acid levels were significantly lower in the retinas of the MPTP-treated animals (p less than 0.001), suggesting that dopamine has a specific function in the visual system of primates. | lld:pubmed |
| pubmed-article:3260986 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3260986 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3260986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3260986 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3260986 | pubmed:issn | 0024-3205 | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:Bodis-Wollner... | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:ChungEE | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:GloverAA | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:OnofrjMM | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:GhilardiM FMF | lld:pubmed |
| pubmed-article:3260986 | pubmed:author | pubmed-author:DvorzniakMM | lld:pubmed |
| pubmed-article:3260986 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3260986 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:3260986 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3260986 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3260986 | pubmed:pagination | 255-62 | lld:pubmed |
| pubmed-article:3260986 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:meshHeading | pubmed-meshheading:3260986-... | lld:pubmed |
| pubmed-article:3260986 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3260986 | pubmed:articleTitle | Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. | lld:pubmed |
| pubmed-article:3260986 | pubmed:affiliation | Dept. of Neurology, Mount Sinai School of Medicine, New York, N.Y. 10029. | lld:pubmed |
| pubmed-article:3260986 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3260986 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3260986 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3260986 | lld:pubmed |
